Search
SectionsIndex
  • Behavior
  • Circulatory System
  • Clinical Pathology and Procedures
  • Digestive System
  • Emergency Medicine and Critical Care
  • Endocrine System
  • Exotic and Laboratory Animals
  • Eye and Ear
  • Generalized Conditions
  • Immune System
  • Integumentary System
  • Management and Nutrition
  • Metabolic Disorders
  • Musculoskeletal System
  • Nervous System
  • Pharmacology
  • Poultry
  • Reproductive System
  • Respiratory System
  • Toxicology
  • Urinary System
  • Zoonoses
ABCDEFGHI
JKLMNOPQR
STUVWXYZ
In This Topic
Musculoskeletal System
Sarcocystosis
Overview of Sarcocystosis
Etiology, Transmission, and Pathogenesis
Clinical Findings
Control
Back to Top
Resources
  • About The Merck Veterinary Manual
  • Reference Guides
  • Multimedia
Manuals available online
'/home/index.html' + bookPageLink
 
'/vet/index.html'
These and other Manuals available
in print, online, and as mobile applications.

See more at MerckManuals.com
Sections in Veterinary Professionals
  • Behavior
  • Circulatory System
  • Clinical Pathology and Procedures
  • Digestive System
  • Emergency Medicine and Critical Care
  • Endocrine System
  • Exotic and Laboratory Animals
  • Eye and Ear
  • Generalized Conditions
  • Immune System
  • Integumentary System
  • Management and Nutrition
  • Metabolic Disorders
  • Musculoskeletal System
  • Nervous System
  • Pharmacology
  • Poultry
  • Reproductive System
  • Respiratory System
  • Toxicology
  • Urinary System
  • Zoonoses
Chapters in Musculoskeletal System
  • Musculoskeletal System Introduction
  • Congenital and Inherited Anomalies of the Musculoskeletal System
  • Dystrophies Associated with Calcium, Phosphorus, and Vitamin D
  • Arthropathies in Large Animals
  • Lameness in Cattle
  • Lameness in Goats
  • Lameness in Horses
  • Lameness in Pigs
  • Lameness in Sheep
  • Myopathies in Ruminants and Pigs
  • Myopathies in Horses
  • Bovine Secondary Recumbency
  • Lameness in Small Animals
  • Arthropathies and Related Disorders in Small Animals
  • Myopathies in Small Animals
  • Osteopathies in Small Animals
  • Sarcocystosis
Topics in Sarcocystosis
  • Overview of Sarcocystosis
         
        • Merck Manual
        • >
        • Veterinary Professionals
        • >
        • Musculoskeletal System
        • >
        • Sarcocystosis
        • 4
         
        Overview of Sarcocystosis

        Share This

        In sarcocystosis, the endothelium and muscles and other soft tissues are invaded by Apicomplexan protozoans of the genus Sarcocystis. As the name implies, Sarcocystis spp (from Greek sarkos: muscle and kystis: cysts) form cysts in muscles of various intermediate hosts—humans, horses, cattle, sheep, goats, pigs, birds, rodents, camelids, wildlife, and reptiles. The cysts vary in size from a few micrometers to several centimeters, depending on the host and species. Most Sarcocystis spp infections are distributed worldwide.

        Etiology, Transmission, and Pathogenesis

        Sarcocystis spp normally develop in 2-host cycles consisting of an intermediate host (prey) and the final host (predator). Species-specific prey-predator life cycles have been demonstrated for cattle-dog (S cruzi), cattle-cat (S hirsuta), cattle-human (S hominis), sheep-dog (S capracanis, S hircicanis), sheep-cat (S gigantea, S medusiformis), goat-dog (S capracanis, S hircicanis), goat-cat (S moulei), pig-dog (S meischeriana), pig-human (S suihominis), pig-cat (S porcifelis), horse-dog (S fayeri), llama-dog (S aucheniae), and others. Some wildlife may serve as intermediate hosts (such as raccoons) or final hosts (coyotes, opossums) for some species of Sarcocystis.

        About 1–2 wk after ingesting muscle tissue that contains Sarcocystis cysts (sarcocysts), the final host begins to shed infective sporocysts in the feces; shedding continues for several months. After ingestion of sporocysts by a suitable intermediate host, sporozoites are liberated and initiate development of schizonts in vascular endothelia of mesenteric arterioles and mesenteric lymph nodes. Merozoites are liberated from the mature schizonts and produce a second generation of endothelial schizonts in capillaries from several organs. Merozoites from this second generation subsequently invade the muscle fibers and develop into the typical sarcocysts. Initially, sarcocysts contain only a few metrocytes—round, noninfective parasites that give rise to the banana-shaped infective zoites (bradyzoites) found in mature cysts beginning 2–3 mo after infection. Sarcocysts of some species are easily visible with the unaided eye (S aucheniae, S hirsuta, S gigantea). The presence of such sarcocysts can cause condemnation of the carcass during meat inspection. Sarcocysts of other species remain microscopic, even though tremendous numbers of cysts may be present in the muscles.

        S cruzi produce microscopic cysts, principally in myocardium, and affect up to 100% of some cattle populations. S hirsuta has been primarily responsible for cattle condemnation for visible sarcocysts. S meischeriana is the most important species affecting pigs and may affect meat quality. Macroscopic cysts of S aucheniae are an important cause of condemnation of llama meat. Sarcocysts are easily recovered from esophagus, diaphragm, and heart muscle.

        In general, Sarcocystis spp infections are considered of low pathogenicity except induced infection with S cruzi sporocysts from canine feces, which may cause acute disease in calves; eosinophilic myositis in cattle; and abortions, stillbirths, and deaths in pregnant cows. Two cases of necrotic encephalitis in heifers have been reported. Similar pathogenicity has been demonstrated for S tenella in lambs and ewes. An outbreak of myositis affecting 20 ewes with flaccid paralysis was a result of heavy Sarcocystis infection. Immune status of the host and the dose of sporocysts may be the most important factors for the development of clinical disease. Pathologic changes in myocardium and skeletal muscles were more pronounced in cows with lymphatic leukemia. “Immunization” using small doses of sporocysts appears to prevent development or reduce severity of clinical disease in sheep when challenged with large doses later (premunitive immunity). In dogs, a longer prepatent period and shortened patent period resulted after repeated infection. Pigs can also have persistent acquired immunity after immunization infections.

        Humans may also serve as intermediate hosts and suffer myositis and vasculitis, but this tissue phase is rare, and the source of such human infection has never been determined. Human intestinal illness as final host, with clinical signs of nausea, abdominal pain, loss of appetite, vomiting, and diarrhea that lasted up to 48 hr, has followed ingestion of sarcocysts of S suihominis in uncooked pork and S hominis in uncooked beef.

        Clinical Findings

        Sarcocystis spp infections are quite prevalent in farm animals; however, there have been few outbreaks of clinical disease. Most animals are asymptomatic, and the parasite is discovered only at slaughter. In cattle severely affected by S cruzi, the signs include fever, anorexia, cachexia, decreased milk yield, diarrhea, muscle spasms, anemia, loss of tail hair, hyperexcitability, weakness, prostration, and death. Cows infected in the last trimester of pregnancy may abort. After recovery from acute illness, calves failed to grow well and eventually died in a cachectic state. Anemia, hepatitis, and myocarditis were the primary lesions in acute ovine sarcocystosis after experimental challenge with S tenella sporocysts. Cases of encephalomyelitis in sheep were associated with a Sarcocystis sp infection. After recovery from acute illness, some sheep may lose their wool. S tenella may also induce abortion in sheep. At necropsy, acutely affected animals have hemorrhage of the serous membranes of the viscera and myocardium. Sarcocystis spp infections are probably most important in growing ruminants and swine, in which they can result in subclinical anemia and reduced weight gain.

        Equine protozoal myeloencephalitis (EPM, see Equine Protozoal Myeloencephalitis) is caused principally by S neurona in American horses. Only asexual stages of this parasite have been found in horses, and they may be located in neurons and leukocytes of the brain and spinal cord. Opossums (Didelphis virginiana and D albiventris) are its definitive hosts. Clinical signs in horses include gait abnormalities such as ataxia, knuckling, and crossing over. Muscle atrophy of the hindlimb, which is usually unilateral, is frequent. The lesions are typically focal, and brain-stem involvement is common. Depression, weakness, head tilt, and dysphagia are other possible signs. EPM can mimic many neurologic diseases. Horses may also develop a myopathy. Multifocal myositis has been reported and is possibly due to another Sarcocystis species with horses as the intermediate host, S fayeri. PCR is an important diagnostic method.

        Control

        Livestock become infected by sporocysts from the feces of carnivores. Because most adult cattle, sheep, and many pigs harbor cysts in their muscles, dogs and other carnivores should not be allowed to eat raw meat, offal, or dead animals. Supplies of grain and feed should be kept covered; dogs and cats should not be allowed in buildings used to store feed or house animals. Amprolium (100 mg/kg, sid for 30 days), fed prophylactically, reduced illness in cattle inoculated with S cruzi. Prophylactic administration of amprolium or salinomycin also protected experimentally infected sheep. Therapeutic treatment of cattle and sheep has been ineffective. Vaccines are not available. Experimental work demonstrated that infected pork and beef could be made safe for consumption by cooking at 70°C for 15 min or by freezing at –4°C for 2 days or –20°C for 1 day.

        Pyrimethamine and sulfadiazine (l mg/kg and 20 mg/kg, respectively, sid for 120 days or longer) are the traditional therapy to treat horses with EPM. Diclazuril and toltrazuril (5 mg/kg) are potentially useful prophylactic agents against S neurona.

        Last full review/revision March 2012 by Gastón A. Moré, MV, DVM

        Buy the Book

        Back to Top

        Previous: Overview of Osteopathies in Small Animals

        Audio
        Figures
        Photographs
        Sidebars
        Tables
        Videos

        Copyright     © 2010-2013 Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Whitehouse Station, N.J., U.S.A.    Privacy    Terms of Use